BIOCONTROL LTD has a total of 37 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are INST NECKER, BOEHRINGER INGELHEIM VETMED and ORBSEN THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 6 | |
#4 | Canada | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Australia | 4 | |
#7 | Japan | 2 | |
#8 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Basic materials chemistry | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Harper David | 25 |
#2 | Hawkins Catherine | 9 |
#3 | Soothill James | 9 |
#4 | Blake Katy | 6 |
#5 | Sommerville Christina | 5 |
#6 | Shaw Karen Joy | 3 |
#7 | Rankin Deborah A | 1 |
#8 | Smrekar Frenk | 1 |
#9 | David Harper | 1 |
#10 | Mearns Gillian | 1 |
Publication | Filing date | Title |
---|---|---|
US2015118191A1 | Therapeutic bacteriophage compositions | |
GB201218083D0 | Therapeutic bacteriophage compositions | |
GB201207910D0 | Therapeutic bacteriophage compositions | |
AU2008224651A1 | Beneficial effects of bacteriophage treatments | |
AU2004258731A1 | Bacteriophage-containing therapeutic agents | |
GB0415061D0 | Control agents | |
GB0410855D0 | Therapeutic agents | |
GB0317240D0 | Therapeutic agents | |
GB0315083D0 | Control agents | |
GB0214937D0 | Control agents | |
EP1357796A2 | Control agents | |
GB0120430D0 | Control agents |